Article Sidebar

Submitted
3 November 2025
Accepted
2 January 2026
Published
30 January 2026
Download
PDF
Statistic
Read Counter : 23 Download : 6

Main Article Content

Abstract

Background: Cardio-Facio-Cutaneous Syndrome is a rare autosomal dominant disorder that is considered as one of the Neuro-Cardio-Facio-Cutaneous syndromes that occur due to genetic mutation. Clinical presentation of this syndrome includes mental retardation, facial features, and others. Objective: The purpose of this article is to describe the clinical manifestations, dental confederations, oral findings, and management strategies in CFC affected paediatric patients. Case description: 9 years old Saudi male presented with his mother to the paediatric dentistry clinic at King Saud Medical City (KSMC), Riyadh, Saudi Arabia. The patient is a known case of Cardio Facio-Cutaneous syndrome and was complaining of dental pain that affected his life quality. Full mouth rehabilitation was done under general anaesthesia setting and the case was followed 14 days after procedure. Conclusion: Strict oral hygiene and preventive measures would help in preventing early tooth loss and eliminate the risk of exposing patients to general anaesthesia. Prenatal and postnatal education is needed to prevent extensive treatment in such cases.

Keywords

Cardio-Facio-Cutaneous Syndrome Oral Manifestations Oral Health Dental Management

Article Details

License

Copyright (c) 2026 Journal of Contemporary Dental Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Almulayfi, A. I., Alsaad, S. S., Alshalaan, A. ., Alassaf, A., Alotaibi, S., Almansour, R. ., & Albarrak, R. (2026). Dental manifestations and management of young patient with Cardio-Facio-Cutaneous syndrome: A case report. Journal of Contemporary Dental Sciences, 3(1), 29–34. Retrieved from https://jcds.qu.edu.sa/index.php/JCDS/article/view/2410
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Pierpont ME, Magoulas PL, Adi S, Kavamura MI, Neri G, Noonan J, et al. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2014;134(4):e1149–62.
  2. Allanson JE, Annerén G, Aoki Y, Armour CM, Bondeson ML, Cave H, et al. Cardio-facio-cutaneous syndrome: does genotype predict phenotype? Am J Med Genet C Semin Med Genet. 2011;157C(2):129–35.
  3. Ou Y, Cao J, Duan Y, Chen F, Zhou J, Li J, et al. Exploring the clinical complexity of cardio-facio-cutaneous syndrome: insights from a pediatric case series. Front Pediatr. 2024;12:1355277.
  4. Gonnella GL, Giuri PP, Zanfini BA, Biancone M, Frassanito L, Olivieri C, et al. Anesthesia management of pediatric dentistry pa-tients with cardiofaciocutaneous syndrome: a case report. Braz J Anesthesiol. 2021;71(2):178–80.
  5. Goodwin AF, Oberoi S, Landan M, Charles C, Groth J, Martinez A, et al. Craniofacial and dental development in car-dio-facio-cutaneous syndrome: the importance of Ras signaling homeostasis. Clin Genet. 2013;83(6):539–44.
  6. 3M ESPE. Scotchbond Etchant #7423 and Etching Liquid #1923 [instructions for use]. St. Paul (MN): 3M ESPE; 2009 Available from: https://media.dentalcompare.com/m/25/Downloads/Scotchbond%20Etchant%20Instructions%20for%20Use.pdf (Accessed 2025 Sep 5).
  7. 3M. 3M Scotchbond Universal Adhesive technique guide. St. Paul (MN): 3M Oral Care; 2017 Available from: https://www.dentaleader.com/content/documents/14-527/135abf56127e7e74ddd9e8978b027e8f.pdf (Accessed 2025 Sep 5).
  8. 3M. GBA Z100 MP Restorative: instructions for use. St. Paul (MN): 3M; 2014 Available from: https://www.mwdental.de/pub/media/documents/8ec3607d416f4c4d8/GBA_Z100%20MP%20Restorative_116154.pdf (Accessed 2025 Sep 5).
  9. Ethicon (Johnson & Johnson MedTech). SURGICEL Powder absorbable hemostat. Raritan (NJ): Johnson & Johnson MedTech; 2022 Available from: https://www.jnjmedtech.com/en-US/product/surgicel-powder-absorbable-hemostat#:~:text=Indication,control%20are%20impractical%20or%20ineffective (Accessed 2025 Sep 5).
  10. Johnson & Johnson MedTech. VICRYL Suture: wound closure product information [PDF]. Auckland (NZ): Johnson & Johnson (New Zealand) Ltd; 2023 Available from: https://www.jnjmedtech.com/system/files/pdf/VICRYL%C2%AE%20Suture.pdf (Accessed 2025 Sep 5).
  11. Bakhsh AA, Shabeeh H, Mannocci F, Niazi SA. A review of guidelines for antibiotic prophylaxis before invasive dental treatments. Appl Sci. 2020;11(1):311.
  12. Yılmaz Uzman C, Gürsoy S, Özkan B, Vuran G, Ayyıldız Emecen D, Köprülü Ö, Bilen MM, Hazan F. Clinical features and mo-lecular genetics of patients with RASopathies: expanding the phenotype with rare genes and novel variants. Eur J Pediatr. 2024;184(1):108.
  13. Denayer E, Legius E. What’s new in the neuro-cardio-facial cutaneous syndromes? Eur J Pediatr. 2007;166(11):1091–8.
  14. Roberts A, Allanson J, Jadico SK, Kavamura MI, Noonan J, Opitz JM, et al. The cardiofaciocutaneous syndrome. J Med Genet. 2006;43(11):833–42.
  15. Azimi S, Wong K, Lai Y, Bourke J, Junaid M, Jones J, et al. Dental procedures in children with or without intellectual disability and autism spectrum disorder in a hospital setting. Aust Dent J. 2022 Dec;67(4):328–39.